Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pegavision Corp. (6491:TWSE), powered by AI.
Pegavision Corp. is currently trading at $311.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pegavision Corp. on Alpha Lenz.
View Pegavision Corp.'s valuation metrics on Alpha Lenz.
“Pegavision Corp.'s ROE is 14.4%. Explore profitability and growth together.”
Ask for details →Pegavision Corp. is a leading company in the optical and eye care industry, primarily engaged in the design, manufacture, and distribution of contact lenses. Established in Taiwan, the company provides an array of products, including daily, bi-weekly, and monthly disposable contact lenses. Pegavision's offerings are notable for their high-quality standards and innovative technologies, such as advanced silicone hydrogel materials that enhance comfort and oxygen permeability, catering to the diverse needs of consumers. The corporation serves a global customer base, including regions across Asia, Europe, and the Americas. Distinguished by its strong emphasis on research and development, Pegavision continually strives to improve eye health solutions and expand its product lines to incorporate new functionalities and designs. In the financial market, Pegavision Corp. plays a critical role in the healthcare and consumer goods sectors, contributing to advancements in eye care technologies and setting benchmarks for quality and innovation within the industry.
“Pegavision Corp.'s ROE is 14.4%. Explore profitability and growth together.”
Ask for details →Pegavision Corp. (ticker: 6491) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).
The current price is 311.5 with a P/E ratio of -x and P/B of -x.
ROE is 14.41% and operating margin is 25.67%. Annual revenue is $7.0B.